Telix Pharmaceuticals Limited (ASX: TLX)

Telix Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	123.24	116.33	22.04	77.95	44.6
Cash & Cash Equivalents	123.24	116.33	22.04	77.95	44.6
Cash Growth	5.94%	427.88%	-71.73%	74.77%	73.05%
Receivables	64.78	45.92	20.85	14.19	13.01
Inventory	17.31	8.48	3.45	0.63	0.54
Other Current Assets	19.52	2.51	1.21	0.86	0.53
Total Current Assets	224.85	173.23	47.54	93.63	58.68
Property, Plant & Equipment	30.49	18.84	6.33	4.82	1.9
Long-Term Investments	12.26	-5.52	0	-4.22	0
Goodwill	4.85	5.52	4.1	4.22	4.22
Intangible Assets	104.82	58.98	55.73	59.19	41.95
Other Long-Term Assets	21.04	9.54	-3.89	6.8	-4.14
Total Long-Term Assets	173.45	87.36	62.27	70.81	43.93
Total Assets	398.3	260.59	109.81	164.44	102.61
Accounts Payable	32.84	16.81	11.88	5.81	6.96
Deferred Revenue	112.02	4.94	6.14	3.24	0
Current Debt	1.56	0.64	0.63	0.77	0.49
Other Current Liabilities	11	63.17	19.32	10.15	3.17
Total Current Liabilities	157.41	85.56	37.98	19.96	10.63
Long-Term Debt	15.89	3.31	1.91	0.1	0.29
Other Long-Term Liabilities	76.1	89.57	66.28	64.39	20.96
Total Long-Term Liabilities	91.98	92.88	68.19	64.49	21.25
Total Liabilities	249.39	178.44	106.17	84.44	31.88
Total Debt	17.45	10.45	2.54	2.21	2.13
Debt Growth	67.00%	311.42%	15.04%	3.57%	23.23%
Common Stock	446.27	370.97	170.84	167.06	115.94
Retained Earnings	-263.67	-272.82	-173.47	-92.96	-48.07
Comprehensive Income	-33.69	-18.15	4.79	4.92	2.21
Shareholders' Equity	148.91	80.01	2.16	79.02	70.08
Total Liabilities and Equity	398.3	260.59	109.81	164.44	102.61
Net Cash / Debt	105.79	105.88	19.5	75.74	42.47
Net Cash / Debt Growth	-0.09%	443.05%	-74.26%	78.35%	76.64%
Net Cash Per Share	0.33	0.34	0.07	0.29	0.18
Working Capital	67.44	87.68	9.56	73.67	48.05
Book Value Per Share	0.47	0.26	0.01	0.31	0.30

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.